Investing.com - Financial Markets Worldwide

Curatis Holding AG (CURN)

Switzerland
Currency in CHF
12.3000
+0.5000(+4.24%)
Closed·
CURN Scorecard
Full Analysis
Suffers from weak gross profit margins
CURN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
12.300012.3000
52 wk Range
5.000018.2000
Key Statistics
Edit
Bid/Ask
12.00 / 12.15
Prev. Close
11.8
Open
12.3
Day's Range
12.3-12.3
52 wk Range
5-18.2
Volume
3.08K
Average Volume (3m)
2.28K
1-Year Change
85.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CURN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 5
Valuation implies a poor free cash flow yield
Unlock InvestingPro

Curatis Holding AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Curatis Holding AG Company Profile

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hyperplasia, immunomodulator, epilepsy and essential tremor, thyreostatic, hereditary tyrosinemia type 1, gastroenterologic, immunomodulator, thyreostatic, tranquilizer, helicobacter pylori test, phosphate binder, special nutrition for dialysis patients, dermato corticosteroid, lead and mercury poisoning, corticostimulin, anti-fog agent, chorea associated with huntington’s disease, and antiepileptic. The company also develops C-PTBE-01, which is in Phase IIb clinical trial for the treatment of peritumoral brain edema in pediatric patients; C-AM-01 that is in Phase IIa clinical trial for the prevention of severe migraine with aura; C-MOH-01, which is in Phase IIa clinical trial for the treatment and prevention of medication overuse headache; and KIN001 that is in Phase I clinical trial for the treatment of rare inflammatory and fibrotic diseases. The company is based in Liestal, Switzerland.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
8
Market
Switzerland

Compare CURN to Peers and Sector

Metrics to compare
CURN
Peers
Sector
Relationship
P/E Ratio
0.0x−0.9x−0.5x
PEG Ratio
0.000.010.00
Price/Book
0.0x0.7x2.6x
Price / LTM Sales
0.0x2.0x3.3x
Upside (Analyst Target)
0.0%163.2%43.5%
Fair Value Upside
Unlock−1.5%6.9%Unlock

Earnings

Latest Release
Aug 31, 2022
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

CURN Income Statement

FAQ

What Stock Exchange Does Curatis Holding Trade On?

Curatis Holding is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for Curatis Holding?

The stock symbol for Curatis Holding is "CURN."

What Is the Curatis Holding Market Cap?

As of today, Curatis Holding market cap is 61.41M.

What Is Curatis Holding's Earnings Per Share (TTM)?

The Curatis Holding EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is CURN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Curatis Holding Stock Split?

Curatis Holding has split 1 times.

How Many Employees Does Curatis Holding Have?

Curatis Holding has 8 employees.

What is the current trading status of Curatis Holding (CURN)?

As of 07 Aug 2025, Curatis Holding (CURN) is trading at a price of 12.30, with a previous close of 11.80. The stock has fluctuated within a day range of 12.30 to 12.30, while its 52-week range spans from 5.00 to 18.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.